Nitric Oxide and Redox Regulation in the Liver: Part I. General Considerations and Redox Biology in Hepatitis

Journal of Surgical Research

Volumn 162, Issue 1, 2010, Pages 95-109

  Diesen, Diana L ^a   Kuo, Paul C ^a  

^a DUKE UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

antioxidants; ethanol induced hepatitis; fibrosis; hepatitis; hepatocytes; ischemia reperfusion; nitric oxide; oxidative stress; proteomics; reactive oxygen species

Indexed keywords

ADENOSINE TRIPHOSPHATE; BILIRUBIN; CALCIUM; CATALASE; CITRULLINE; CYTOCHROME P450; FREE RADICAL; GAMMA INTERFERON; GLUTATHIONE; GLUTATHIONE PEROXIDASE; HEME OXYGENASE; HYDROGEN PEROXIDE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 1BETA; MELATONIN; NITRIC OXIDE; PEROXYNITRITE; REACTIVE NITROGEN SPECIES; REACTIVE OXYGEN METABOLITE; SUPEROXIDE DISMUTASE; THIOCTIC ACID; THIOREDOXIN; TUMOR NECROSIS FACTOR; TUMOR NECROSIS FACTOR ALPHA; TUMOR NECROSIS FACTOR RELATED APOPTOSIS INDUCING LIGAND; UBIQUINONE; URIC ACID;

APOPTOSIS; ATHEROSCLEROSIS; BLOOD VESSEL TONE; CATARACT; CELL DAMAGE; CELL DEATH; CELL REGENERATION; CYSTIC FIBROSIS; DIABETES MELLITUS; GENE EXPRESSION; HEART MUSCLE CONTRACTILITY; HEPATITIS; HOMEOSTASIS; INFLAMMATION; ISCHEMIA; KUPFFER CELL; LIVER; LIVER CELL; LIVER CIRRHOSIS; LIVER DISEASE; LIVER RESECTION; MITOCHONDRION; MOLECULAR WEIGHT; NEUTROPHIL; OXIDATION; OXIDATIVE STRESS; PHOSPHORYLATION; PRIORITY JOURNAL; RESPIRATORY DISTRESS SYNDROME; RETINA MACULA DEGENERATION; REVIEW; SIGNAL TRANSDUCTION; STELLATE CELL; SYSTEMATIC REVIEW; THROMBOCYTE AGGREGATION;

ANIMALS; HEPATITIS; HEPATOCYTES; HUMANS; LIVER; NITRIC OXIDE; OXIDATION-REDUCTION; OXIDATIVE STRESS; REACTIVE NITROGEN SPECIES; REACTIVE OXYGEN SPECIES;

EID: 77953293358     PISSN: 00224804     EISSN: 10958673     Source Type: Journal    
DOI: 10.1016/j.jss.2009.09.019     Document Type: Review

References (171)

1. Sies H. Oxidative stress:introductory remarks (1985), Academic Press, London
2. Kang K.J. Mechanism of hepatic ischemia/reperfusion injury and protection against reperfusion injury. Transplant Proc 34 (2002) 2659
3. Lieber C.S. Role of oxidative stress and antioxidant therapy in alcoholic and nonalcoholic liver diseases. Adv Pharmacol 38 (1997) 601
4. Jaeschke H. Reactive oxygen and mechanisms of inflammatory liver injury. J Gastroenterol Hepatol 15 (2000) 718
5. Halliwell B., and Gutteridge J. Free Radicals in Biology and Medicine (2007), Oxford University Press, Oxford
6. Nohl H., Gille L., Kozlov A., et al. Are mitochondria a spontaneous and permanent source of reactive oxygen species?. Redox Rep 8 (2003) 135
7. Sutton H.C., and Winterbourn C.C. On the participation of higher oxidation states of iron and copper in Fenton reactions. Free Radic Biol Med 6 (1989) 53
8. Lander H.M. An essential role for free radicals and derived species in signal transduction. FASEB J 11 (1997) 118
9. Chung K.C., Park J.H., Kim C.H., et al. Tumor necrosis factor-alpha and phorbol 12-myristate 13-acetate differentially modulate cytotoxic effect of nitric oxide generated by serum deprivation in neuronal PC12 cells. J Neurochem 72 (1999) 1482
10. Li J., Bombeck C.A., Yang S., et al. Nitric oxide suppresses apoptosis via interrupting caspase activation and mitochondrial dysfunction in cultured hepatocytes. J Biol Chem 274 (1999) 17325
11. Glantzounis G.K., Salacinski H.J., Yang W., et al. The contemporary role of antioxidant therapy in attenuating liver ischemia-reperfusion injury: a review. Liver Transpl 11 (2005) 1031
12. Gutteridge J.M. Iron and oxygen: a biologically damaging mixture. Acta Paediatr Scand Suppl 361 (1989) 78
13. Traber M.G. Determinants of plasma vitamin E concentrations. Free Radic Biol Med 16 (1994) 229
14. Halliwell B., and Gutteridge J.M. The antioxidants of human extracellular fluids. Arch Biochem Biophys 280 (1990) 1
15. Birlouez-Aragon I., and Tessier F.J. Antioxidant vitamins and degenerative pathologies. A review of vitamin C. J Nutr Health Aging 7 (2003) 103
16. Liebler D.C., and McClure T.D. Antioxidant reactions of beta-carotene: identification of carotenoid-radical adducts. Chem Res Toxicol 9 (1996) 8
17. Stamler J.S. Redox signaling: nitrosylation and related target interactions of nitric oxide. Cell 78 (1994) 931
18. Khatsenko O.G., Gross S.S., Rifkind A.B., et al. Nitric oxide is a mediator of the decrease in cytochrome P450-dependent metabolism caused by immunostimulants. Proc Natl Acad Sci U S A 90 (1993) 11147
19. Stadler J., Trockfeld J., Schmalix W.A., et al. Inhibition of cytochromes P4501A by nitric oxide. Proc Natl Acad Sci U S A 91 (1994) 3559
20. Wink D.A., Osawa Y., Darbyshire J.F., et al. Inhibition of cytochromes P450 by nitric oxide and a nitric oxide-releasing agent. Arch Biochem Biophys 300 (1993) 115
21. Schweizer M., and Richter C. Nitric oxide potently and reversibly deenergizes mitochondria at low oxygen tension. Biochem Biophys Res Commun 204 (1994) 169
22. Giuffre A., Sarti P., D'Itri E., et al. On the mechanism of inhibition of cytochrome c oxidase by nitric oxide. J Biol Chem 271 (1996) 33404
23. Griscavage J.M., Hobbs A.J., and Ignarro L.J. Negative modulation of nitric oxide synthase by nitric oxide and nitroso compounds. Adv Pharmacol 34 (1995) 215
24. Brown G.C. Reversible binding and inhibition of catalase by nitric oxide. Eur J Biochem 232 (1995) 188
25. Butler A.R., and Rhodes P. Chemistry, analysis, and biological roles of S-nitrosothiols. Anal Biochem 249 (1997) 1
26. Sumbayev V.V., Budde A., Zhou J., et al. HIF-1 alpha protein as a target for S-nitrosation. FEBS Lett 535 (2003) 106
27. Espey M.G., Miranda K.M., Thomas D.D., et al. Distinction between nitrosating mechanisms within human cells and aqueous solution. J Biol Chem 276 (2001) 30085
28. Espey M.G., Thomas D.D., Miranda K.M., et al. Focusing of nitric oxide mediated nitrosation and oxidative nitrosylation as a consequence of reaction with superoxide. Proc Natl Acad Sci U S A 99 (2002) 11127
29. O'Reilly P., Hickman-Davis J.M., McArdle P., et al. The role of nitric oxide in lung innate immunity: modulation by surfactant protein-A. Mol Cell Biochem 234-235 (2002) 39
30. Knight T.R., Kurtz A., Bajt M.L., et al. Vascular and hepatocellular peroxynitrite formation during acetaminophen toxicity: role of mitochondrial oxidant stress. Toxicol Sci 62 (2001) 212
31. Chartrain N.A., Geller D.A., Koty P.P., et al. Molecular cloning, structure, and chromosomal localization of the human inducible nitric oxide synthase gene. J Biol Chem 269 (1994) 6765
32. Taylor B.S., Alarcon L.H., and Billiar T.R. Inducible nitric oxide synthase in the liver: regulation and function. Biochemistry (Mosc) 63 (1998) 766
33. Curran R.D., Billiar T.R., Stuehr D.J., et al. Hepatocytes produce nitrogen oxides from L-arginine in response to inflammatory products of Kupffer cells. J Exp Med 170 (1989) 1769
34. Billiar T.R., Curran R.D., Stuehr D.J., et al. An L-arginine-dependent mechanism mediates Kupffer cell inhibition of hepatocyte protein synthesis in vitro. J Exp Med 169 (1989) 1467
35. Spitzer J.A. Cytokine stimulation of nitric oxide formation and differential regulation in hepatocytes and nonparenchymal cells of endotoxemic rats. Hepatology 19 (1994) 217
36. Schmidt H.H., Pollock J.S., Nakane M., et al. Purification of a soluble isoform of guanylyl cyclase-activating-factor synthase. Proc Natl Acad Sci U S A 88 (1991) 365
37. Curran R.D., Billiar T.R., Stuehr D.J., et al. Multiple cytokines are required to induce hepatocyte nitric oxide production and inhibit total protein synthesis. Ann Surg 212 (1990) 462 discussion 470
38. Geller D.A., Nussler A.K., Di Silvio M., et al. Cytokines, endotoxin, and glucocorticoids regulate the expression of inducible nitric oxide synthase in hepatocytes. Proc Natl Acad Sci USA 90 (1993) 522
39. Taylor B.S., and Geller D.A. Molecular regulation of the human inducible nitric oxide synthase (iNOS) gene. Shock 13 (2000) 413
40. Sakitani K., Nishizawa M., Inoue K., et al. Synergistic regulation of inducible nitric oxide synthase gene by CCAAT/enhancer-binding protein beta and nuclear factor-kappaB in hepatocytes. Genes Cells 3 (1998) 321
41. Li J., and Billiar T.R. Nitric Oxide. IV. Determinants of nitric oxide protection and toxicity in liver. Am J Physiol 276 (1999) G1069
42. Bursch W., Oberhammer F., Jirtle R.L., et al. Transforming growth factor-beta 1 as a signal for induction of cell death by apoptosis. Br J Cancer 67 (1993) 531
43. Fiorucci S., Mencarelli A., Palazzetti B., et al. An NO derivative of ursodeoxycholic acid protects against Fas-mediated liver injury by inhibiting caspase activity. Proc Natl Acad Sci USA 98 (2001) 2652
44. Kim Y.M., de Vera M.E., Watkins S.C., et al. Nitric oxide protects cultured rat hepatocytes from tumor necrosis factor-alpha-induced apoptosis by inducing heat shock protein 70 expression. J Biol Chem 272 (1997) 1402
45. Hug H., Strand S., Grambihler A., et al. Reactive oxygen intermediates are involved in the induction of CD95 ligand mRNA expression by cytostatic drugs in hepatoma cells. J Biol Chem 272 (1997) 28191
46. Canbay A., Feldstein A.E., Higuchi H., et al. Kupffer cell engulfment of apoptotic bodies stimulates death ligand and cytokine expression. Hepatology 38 (2003) 1188
47. Jones B.E., Lo C.R., Liu H., et al. Hepatocytes sensitized to tumor necrosis factor-alpha cytotoxicity undergo apoptosis through caspase-dependent and caspase-independent pathways. J Biol Chem 275 (2000) 705
48. Muller M., Strand S., Hug H., et al. Drug-induced apoptosis in hepatoma cells is mediated by the CD95 (APO-1/Fas) receptor/ligand system and involves activation of wild-type p53. J Clin Invest 99 (1997) 403
49. Sun X., Majumder P., Shioya H., et al. Activation of the cytoplasmic c-Abl tyrosine kinase by reactive oxygen species. J Biol Chem 275 (2000) 17237
50. Laskin D.L., Heck D.E., Gardner C.R., et al. Distinct patterns of nitric oxide production in hepatic macrophages and endothelial cells following acute exposure of rats to endotoxin. J Leukoc Biol 56 (1994) 751
51. Laskin D.L., Rodriguez del Valle M., Heck D.E., et al. Hepatic nitric oxide production following acute endotoxemia in rats is mediated by increased inducible nitric oxide synthase gene expression. Hepatology 22 (1995) 223
52. Fehsel K., Kroncke K.D., Meyer K.L., et al. Nitric oxide induces apoptosis in mouse thymocytes. J Immunol 155 (1995) 2858
53. Kurose I., Higuchi H., Yonei Y., et al. Rat Kupffer cell-derived nitric oxide suppresses proliferation and induces apoptosis of syngeneic hepatoma cells. Gastroenterology 111 (1996) 1058
54. Wang H.H., McIntosh A.R., Hasinoff B.B., et al. B16 melanoma cell arrest in the mouse liver induces nitric oxide release and sinusoidal cytotoxicity: a natural hepatic defense against metastasis. Cancer Res 60 (2000) 5862
55. Tzeng E., Billiar T.R., Williams D.L., et al. Adenovirus-mediated inducible nitric oxide synthase gene transfer inhibits hepatocyte apoptosis. Surgery 124 (1998) 278
56. Martin-Sanz P., Hortelano S., Callejas N.A., et al. Nitric oxide in liver inflammation and regeneration. Metab Brain Dis 17 (2002) 325
57. Kim Y.M., Talanian R.V., and Billiar T.R. Nitric oxide inhibits apoptosis by preventing increases in caspase-3-like activity via two distinct mechanisms. J Biol Chem 272 (1997) 31138
58. Li J., Billiar T.R., Talanian R.V., et al. Nitric oxide reversibly inhibits seven members of the caspase family via S-nitrosylation. Biochem Biophys Res Commun 240 (1997) 419
59. Kim Y.M., Chung H.T., Simmons R.L., et al. Cellular non-heme iron content is a determinant of nitric oxide-mediated apoptosis, necrosis, and caspase inhibition. J Biol Chem 275 (2000) 10954
60. Kim Y.M., Kim T.H., Chung H.T., et al. Nitric oxide prevents tumor necrosis factor alpha-induced rat hepatocyte apoptosis by the interruption of mitochondrial apoptotic signaling through S-nitrosylation of caspase-8. Hepatology 32 (2000) 770
61. Marshall H.E., and Stamler J.S. Nitrosative stress-induced apoptosis through inhibition of NF-kappa B. J Biol Chem 277 (2002) 34223
62. Mannick J.B., Hausladen A., Liu L., et al. Fas-induced caspase denitrosylation. Science 284 (1999) 651
63. Hortelano S., Dewez B., Genaro A.M., et al. Nitric oxide is released in regenerating liver after partial hepatectomy. Hepatology 21 (1995) 776
64. Rai R.M., Lee F.Y., Rosen A., et al. Impaired liver regeneration in inducible nitric oxide synthasedeficient mice. Proc Natl Acad Sci U S A 95 (1998) 13829
65. Carnovale C.E., Scapini C., Alvarez M.L., et al. Nitric oxide release and enhancement of lipid peroxidation in regenerating rat liver. J Hepatol 32 (2000) 798
66. Clavien P.A. IL-6, a key cytokine in liver regeneration. Hepatology 25 (1997) 1294
67. Yamada Y., Kirillova I., Peschon J.J., et al. Initiation of liver growth by tumor necrosis factor: deficient liver regeneration in mice lacking type I tumor necrosis factor receptor. Proc Natl Acad Sci U S A 94 (1997) 1441
68. Diaz-Guerra M.J., Velasco M., Martin-Sanz P., et al. Nuclear factor kappaB is required for the transcriptional control of type II NO synthase in regenerating liver. Biochem J 326 Pt 3 (1997) 791
69. Li W., Liang X., Kellendonk C., et al. STAT3 contributes to the mitogenic response of hepatocytes during liver regeneration. J Biol Chem 277 (2002) 28411
70. Cressman D.E., Greenbaum L.E., DeAngelis R.A., et al. Liver failure and defective hepatocyte regeneration in interleukin-6-deficient mice. Science 274 (1996) 1379
71. Akerman P., Cote P., Yang S.Q., et al. Antibodies to tumor necrosis factor-alpha inhibit liver regeneration after partial hepatectomy. Am J Physiol 263 (1992) G579
72. Loguercio C., and Federico A. Oxidative stress in viral and alcoholic hepatitis. Free Radic Biol Med 34 (2003) 1
73. Cardin R., Saccoccio G., Masutti F., et al. DNA oxidative damage in leukocytes correlates with the severity of HCV-related liver disease: validation in an open population study. J Hepatol 34 (2001) 587
74. Lieber C.S., and DeCarli L.M. Ethanol oxidation by hepatic microsomes: adaptive increase after ethanol feeding. Science 162 (1968) 917
75. Lieber C.S. Hepatic, metabolic and toxic effects of ethanol: 1991 update. Alcohol Clin Exp Res 15 (1991) 573
76. Lieber C.S. Alcohol and the liver: 1994 update. Gastroenterology 106 (1994) 1085
77. Tsutsumi M., Lasker J.M., Takahashi T., et al. In vivo induction of hepatic P4502E1 by ethanol: role of increased enzyme synthesis. Arch Biochem Biophys 304 (1993) 209
78. Dryden Jr. G.W., Deaciuc I., Arteel G., et al. Clinical implications of oxidative stress and antioxidant therapy. Curr Gastroenterol Rep 7 (2005) 308
79. Morimoto M., Hagbjork A.L., Nanji A.A., et al. Role of cytochrome P4502E1 in alcoholic liver disease pathogenesis. Alcohol 10 (1993) 459
80. Stal P., Johansson I., Ingelman-Sundberg M., et al. Hepatotoxicity induced by iron overload and alcohol. Studies on the role of chelatable iron, cytochrome P450 2E1 and lipid peroxidation. J Hepatol 25 (1996) 538
81. Cederbaum A.I. Ethanol-related cytotoxicity catalyzed by CYP2E1-dependent generation of reactive oxygen intermediates in transduced HepG2 cells. Biofactors 8 (1998) 93
82. Roman J., Colell A., Blasco C., et al. Differential role of ethanol and acetaldehyde in the induction of oxidative stress in HEP G2 cells: effect on transcription factors AP-1 and NF-kappaB. Hepatology 30 (1999) 1473
83. Poli G., and Parola M. Oxidative damage and fibrogenesis. Free Radic Biol Med 22 (1997) 287
84. Pennington H.L., Hall P.M., Wilce P.A., et al. Ethanol feeding enhances inflammatory cytokine expression in lipopolysaccharide-induced hepatitis. J Gastroenterol Hepatol 12 (1997) 305
85. Nanji A.A., Mendenhall C.L., and French S.W. Beef fat prevents alcoholic liver disease in the rat. Alcohol Clin Exp Res 13 (1989) 15
86. Kessova I.G., Ho Y.S., Thung S., et al. Alcohol-induced liver injury in mice lacking Cu, Zn-superoxide dismutase. Hepatology 38 (2003) 1136
87. Lu S.C., Alvarez L., Huang Z.Z., et al. Methionine adenosyltransferase 1A knockout mice are predisposed to liver injury and exhibit increased expression of genes involved in proliferation. Proc Natl Acad Sci USA 98 (2001) 5560
88. Lieber C.S. S-Adenosyl-L-methionine and alcoholic liver disease in animal models: implications for early intervention in human beings. Alcohol 27 (2002) 173
89. Wheeler M.D., Nakagami M., Bradford B.U., et al. Overexpression of manganese superoxide dismutase prevents alcohol-induced liver injury in the rat. J Biol Chem 276 (2001) 36664
90. Bondy S.C. Ethanol toxicity and oxidative stress. Toxicol Lett 63 (1992) 231
91. Koop D.R., and Tierney D.J. Multiple mechanisms in the regulation of ethanol-inducible cytochrome P450IIE1. Bioessays 12 (1990) 429
92. Koop D.R. Oxidative and reductive metabolism by cytochrome P450 2E1. FASEB J 6 (1992) 724
93. Koop D.R., Chernosky A., and Brass E.P. Identification and induction of cytochrome P450 2E1 in rat Kupffer cells. J Pharmacol Exp Ther 258 (1991) 1072
94. Tsutsumi M., Takada A., and Wang J.S. Genetic polymorphisms of cytochrome P4502E1 related to the development of alcoholic liver disease. Gastroenterology 107 (1994) 1430
95. Ekstrom G., and Ingelman-Sundberg M. Rat liver microsomal NADPH-supported oxidase activity and lipid peroxidation dependent on ethanol-inducible cytochrome P-450 (P-450IIE1). Biochem Pharmacol 38 (1989) 1313
96. Albano E., Tomasi A., Goria-Gatti L., et al. Spin trapping of free radical species produced during the microsomal metabolism of ethanol. Chem Biol Interact 65 (1988) 223
97. Morgan K., French S.W., and Morgan T.R. Production of a cytochrome P450 2E1 transgenic mouse and initial evaluation of alcoholic liver damage. Hepatology 36 (2002) 122
98. Knecht K.T., Bradford B.U., Mason R.P., et al. In vivo formation of a free radical metabolite of ethanol. Mol Pharmacol 38 (1990) 26
99. Morimoto M., Hagbjork A.L., Wan Y.J., et al. Modulation of experimental alcohol-induced liver disease by cytochrome P450 2E1 inhibitors. Hepatology 21 (1995) 1610
100. Albano E., Clot P., Morimoto M., et al. Role of cytochrome P4502E1-dependent formation of hydroxyethyl free radical in the development of liver damage in rats intragastrically fed with ethanol. Hepatology 23 (1996) 155
101. Lluis J.M., Colell A., Garcia-Ruiz C., et al. Acetaldehyde impairs mitochondrial glutathione transport in HepG2 cells through endoplasmic reticulum stress. Gastroenterology 124 (2003) 708
102. Lu S.C., Tsukamoto H., and Mato J.M. Role of abnormal methionine metabolism in alcoholic liver injury. Alcohol 27 (2002) 155
103. Colell A., Garcia-Ruiz C., Miranda M., et al. Selective glutathione depletion of mitochondria by ethanol sensitizes hepatocytes to tumor necrosis factor. Gastroenterology 115 (1998) 1541
104. Paredes S.R., Kozicki P.A., Fukuda H., et al. S-adenosyl-L-methionine: its effect on aminolevulinate dehydratase and glutathione in acute ethanol intoxication. Alcohol 4 (1987) 81
105. Dworkin B., Rosenthal W.S., Jankowski R.H., et al. Low blood selenium levels in alcoholics with and without advanced liver disease. Correlations with clinical and nutritional status. Dig Dis Sci 30 (1985) 838
106. Leo M.A., and Lieber C.S. Hepatic vitamin A depletion in alcoholic liver injury. N Engl J Med 307 (1982) 597
107. Thurnham D.I., Davies J.A., Crump B.J., et al. The use of different lipids to express serum tocopherol: lipid ratios for the measurement of vitamin E status. Ann Clin Biochem 23 Pt 5 (1986) 514
108. Bianchi G.P., Fiorella P.L., Bargossi A.M., et al. Reduced ubiquinone plasma levels in patients with liver cirrhosis and in chronic alcoholics. Liver 14 (1994) 138
109. Zima T., Fialova L., Mestek O., et al. Oxidative stress, metabolism of ethanol and alcohol-related diseases. J Biomed Sci 8 (2001) 59
110. Chamulitrat W., and Spitzer J.J. Nitric oxide and liver injury in alcohol-fed rats after lipopolysaccharide administration. Alcohol Clin Exp Res 20 (1996) 1065
111. Alam K., Nagi M.N., Al-Shabanah O.A., et al. Beneficial effect of nitric oxide synthase inhibitor on hepatotoxicity induced by allyl alcohol. J Biochem Mol Toxicol 15 (2001) 317
112. Oshita M., Takei Y., Kawano S., et al. Endogenous nitric oxide attenuates ethanol-induced perturbation of hepatic circulation in the isolated perfused rat liver. Hepatology 20 (1994) 961
113. Kono H., Rusyn I., Yin M., et al. NADPH oxidase-derived free radicals are key oxidants in alcohol-induced liver disease. J Clin Invest 106 (2000) 867
114. McKim S.E., Gabele E., Isayama F., et al. Inducible nitric oxide synthase is required in alcohol-induced liver injury: studies with knockout mice. Gastroenterology 125 (2003) 1834
115. Clot P., Tabone M., Arico S., et al. Monitoring oxidative damage in patients with liver cirrhosis and different daily alcohol intake. Gut 35 (1994) 1637
116. Paradis V., Kollinger M., Fabre M., et al. In situ detection of lipid peroxidation by-products in chronic liver diseases. Hepatology 26 (1997) 135
117. Situnayake R.D., Crump B.J., Thurnham D.I., et al. Lipid peroxidation and hepatic antioxidants in alcoholic liver disease. Gut 31 (1990) 1311
118. Kamimura S., Gaal K., Britton R.S., et al. Increased 4-hydroxynonenal levels in experimental alcoholic liver disease: association of lipid peroxidation with liver fibrogenesis. Hepatology 16 (1992) 448
119. Parola M., Pinzani M., Casini A., et al. Stimulation of lipid peroxidation or 4-hydroxynonenal treatment increases procollagen alpha 1 (I) gene expression in human liver fat-storing cells. Biochem Biophys Res Commun 194 (1993) 1044
120. Leonarduzzi G., Scavazza A., Biasi F., et al. The lipid peroxidation end product 4-hydroxy-2,3-nonenal up-regulates transforming growth factor beta1 expression in the macrophage lineage: a link between oxidative injury and fibrosclerosis. FASEB J 11 (1997) 851
121. Cajone F., and Bernelli-Zazzera A. The action of 4-hydroxynonenal on heat shock gene expression in cultured hepatoma cells. Free Radic Res Commun 7 (1989) 189
122. Niemela O., Parkkila S., Bradford B., et al. Effect of Kupffer cell inactivation on ethanol-induced protein adducts in the liver. Free Radic Biol Med 33 (2002) 350
123. Arteel G.E. Oxidants and antioxidants in alcohol-induced liver disease. Gastroenterology 124 (2003) 778
124. Joshi-Barve S., Barve S.S., Butt W., et al. Inhibition of proteasome function leads to NF-kappaB-independent IL-8 expression in human hepatocytes. Hepatology 38 (2003) 1178
125. McClain C.J., and Cohen D.A. Increased tumor necrosis factor production by monocytes in alcoholic hepatitis. Hepatology 9 (1989) 349
126. Ponnappa B.C., Israel Y., Aini M., et al. Inhibition of tumor necrosis factor alpha secretion and prevention of liver injury in ethanol-fed rats by antisense oligonucleotides. Biochem Pharmacol 69 (2005) 569
127. Stewart S.F., Vidali M., Day C.P., et al. Oxidative stress as a trigger for cellular immune responses in patients with alcoholic liver disease. Hepatology 39 (2004) 197
128. Benedetti A., Brunelli E., Risicato R., et al. Subcellular changes and apoptosis induced by ethanol in rat liver. J Hepatol 6 (1988) 137
129. Goldin R.D., Hunt N.C., Clark J., et al. Apoptotic bodies in a murine model of alcoholic liver disease: reversibility of ethanol-induced changes. J Pathol 171 (1993) 73
130. Okuda M., Li K., Beard M.R., et al. Mitochondrial injury, oxidative stress, and antioxidant gene expression are induced by hepatitis C virus core protein. Gastroenterology 122 (2002) 366
131. Choi J., and Ou J.H. Mechanisms of liver injury. III. Oxidative stress in the pathogenesis of hepatitis C virus. Am J Physiol Gastrointest Liver Physiol 290 (2006) G847
132. Gong G., Waris G., Tanveer R., et al. Human hepatitis C virus NS5A protein alters intracellular calcium levels, induces oxidative stress, and activates STAT-3 and NF-kappa B. Proc Natl Acad Sci U S A 98 (2001) 9599
133. Bureau C., Bernad J., Chaouche N., et al. Nonstructural 3 protein of hepatitis C virus triggers an oxidative burst in human monocytes via activation of NADPH oxidase. J Biol Chem 276 (2001) 23077
134. Choi J., Lee K.J., Zheng Y., et al. Reactive oxygen species suppress hepatitis C virus RNA replication in human hepatoma cells. Hepatology 39 (2004) 81
135. Farinati F., Cardin R., Degan P., et al. Oxidative DNA damage in circulating leukocytes occurs as an early event in chronic HCV infection. Free Radic Biol Med 27 (1999) 1284
136. Mahmood S., Kawanaka M., Kamei A., et al. Immunohistochemical evaluation of oxidative stress markers in chronic hepatitis C. Antioxid Redox Signal 6 (2004) 19
137. Sumida Y., Nakashima T., Yoh T., et al. Serum thioredoxin levels as an indicator of oxidative stress in patients with hepatitis C virus infection. J Hepatol 33 (2000) 616
138. Kitada T., Seki S., Iwai S., et al. In situ detection of oxidative DNA damage, 8-hydroxydeoxyguanosine, in chronic human liver disease. J Hepatol 35 (2001) 613
139. Forman H.J.T.M., and Fukuto J. Signal Transduction by Reactive Oxygen and Nitrogen Species: Pathways and Chemical Principles (2003), Kluwer Academic, Boston
140. Thoren F., Romero A., Lindh M., et al. A hepatitis C virus-encoded, nonstructural protein (NS3) triggers dysfunction and apoptosis in lymphocytes: role of NADPH oxidase-derived oxygen radicals. J Leukoc Biol 76 (2004) 1180
141. Korenaga M., Okuda M., Otani K., et al. Mitochondrial dysfunction in hepatitis C. J Clin Gastroenterol 39 (2005) S162
142. Korenaga M., Wang T., Li Y., et al. Hepatitis C virus core protein inhibits mitochondrial electron transport and increases reactive oxygen species (ROS) production. J Biol Chem 280 (2005) 37481
143. Abdalla M.Y., Ahmad I.M., Spitz D.R., et al. Hepatitis C virus-core and non structural proteins lead to different effects on cellular antioxidant defenses. J Med Virol 76 (2005) 489
144. Moriya K., Nakagawa K., Santa T., et al. Oxidative stress in the absence of inflammation in a mouse model for hepatitis C virus-associated hepatocarcinogenesis. Cancer Res 61 (2001) 4365
145. Tardif K.D., Waris G., and Siddiqui A. Hepatitis C virus, ER stress, and oxidative stress. Trends Microbiol 13 (2005) 159
146. Majano P.L., Garcia-Monzon C., Lopez-Cabrera M., et al. Inducible nitric oxide synthase expression in chronic viral hepatitis. Evidence for a virus-induced gene upregulation. J Clin Invest 101 (1998) 1343
147. Machida K., Cheng K.T., Sung V.M., et al. Hepatitis C virus infection activates the immunologic (type II) isoform of nitric oxide synthase and thereby enhances DNA damage and mutations of cellular genes. J Virol 78 (2004) 8835
148. Kandemir O., Polat A., and Kaya A. Inducible nitric oxide synthase expression in chronic viral hepatitis and its relation with histological severity of disease. J Viral Hepat 9 (2002) 419
149. Garcia-Monzon C., Majano P.L., Zubia I., et al. Intrahepatic accumulation of nitrotyrosine in chronic viral hepatitis is associated with histological severity of liver disease. J Hepatol 32 (2000) 331
150. Lake-Bakaar G., Sorbi D., and Mazzoccoli V. Nitric oxide and chronic HCV and HIV infections. Dig Dis Sci 46 (2001) 1072
151. Schweyer S., Mihm S., Radzun H.J., et al. Liver infiltrating T lymphocytes express interferon gamma and inducible nitric oxide synthase in chronic hepatitis C virus infection. Gut 46 (2000) 255
152. Rahman M.A., Dhar D.K., Yamaguchi E., et al. Coexpression of inducible nitric oxide synthase and COX-2 in hepatocellular carcinoma and surrounding liver: possible involvement of COX-2 in the angiogenesis of hepatitis C virus-positive cases. Clin Cancer Res 7 (2001) 1325
153. Ludwig J., Viggiano T.R., McGill D.B., et al. Nonalcoholic steatohepatitis: Mayo Clinic experiences with a hitherto unnamed disease. Mayo Clin Proc 55 (1980) 434
154. James O.F., and Day C.P. Non-alcoholic steatohepatitis (NASH): a disease of emerging identity and importance. J Hepatol 29 (1998) 495
155. Albano E., Mottaran E., Vidali M., et al. Immune response towards lipid peroxidation products as a predictor of progression of non-alcoholic fatty liver disease to advanced fibrosis. Gut 54 (2005) 987
156. Zamara E., Novo E., Marra F., et al. 4-Hydroxynonenal as a selective pro-fibrogenic stimulus for activated human hepatic stellate cells. J Hepatol 40 (2004) 60
157. Ikura Y., Ohsawa M., Suekane T., et al. Localization of oxidized phosphatidylcholine in nonalcoholic fatty liver disease: impact on disease progression. Hepatology 43 (2006) 506
158. Feldstein A.E., Werneburg N.W., Canbay A., et al. Free fatty acids promote hepatic lipotoxicity by stimulating TNF-alpha expression via a lysosomal pathway. Hepatology 40 (2004) 185
159. Crespo J., Cayon A., Fernandez-Gil P., et al. Gene expression of tumor necrosis factor alpha and TNF-receptors, p55 and p75, in nonalcoholic steatohepatitis patients. Hepatology 34 (2001) 1158
160. Feldstein A.E., Canbay A., Angulo P., et al. Hepatocyte apoptosis and fas expression are prominent features of human nonalcoholic steatohepatitis. Gastroenterology 125 (2003) 437
161. Furukawa S., Fujita T., Shimabukuro M., et al. Increased oxidative stress in obesity and its impact on metabolic syndrome. J Clin Invest 114 (2004) 1752
162. Baskol G., Baskol M., and Kocer D. Oxidative stress and antioxidant defenses in serum of patients with non-alcoholic steatohepatitis. Clin Biochem 40 (2007) 776
163. Emery M.G., Fisher J.M., Chien J.Y., et al. CYP2E1 activity before and after weight loss in morbidly obese subjects with nonalcoholic fatty liver disease. Hepatology 38 (2003) 428
164. Sumida Y., Nakashima T., Yoh T., et al. Serum thioredoxin levels as a predictor of steatohepatitis in patients with nonalcoholic fatty liver disease. J Hepatol 38 (2003) 32
165. Sastre J., Pallardo F.V., Llopis J., et al. Glutathione depletion by hyperphagia-induced obesity. Life Sci 45 (1989) 183
166. Strauss R.S., Barlow S.E., and Dietz W.H. Prevalence of abnormal serum aminotransferase values in overweight and obese adolescents. J Pediatr 136 (2000) 727
167. Stadtman ER. NHLBI Research at the Bethesda Campus: Enzyme Section.
168. Cesaratto L., Vascotto C., Calligaris S., et al. The importance of redox state in liver damage. Ann Hepatol 3 (2004) 86
169. Hess D.T., Matsumoto A., Kim S.O., et al. Protein S-nitrosylation: purview and parameters. Nat Rev Mol Cell Biol 6 (2005) 150
170. Perlemuter G., Bigorgne A., Cassard-Doulcier A.M., et al. Nonalcoholic fatty liver disease: from pathogenesis to patient care. Nat Clin Pract Endocrinol Metab 3 (2007) 458
171. Klaunig J.E., and Kamendulis L.M. The role of oxidative stress in carcinogenesis. Annu Rev Pharmacol Toxicol 44 (2004) 239